 - Patients who have had chemotherapy or radiotherapy within 2 weeks 6 weeks for nitrosoureas or mitomycin C prior to entering the study or those who have not recovered from adverse events other than alopecia due to agents administered more than 2 weeks earlier; however, the following therapies are allowed: 